Notice of Closed Meeting, 15432 [2022-05751]

Download as PDF 15432 Federal Register / Vol. 87, No. 53 / Friday, March 18, 2022 / Notices Review Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop S106–9, Atlanta, Georgia 30341, Telephone (404) 639–6473, AWilkes@ cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–05748 Filed 3–17–22; 8:45 am] Date: April 13, 2022. Time: 9:00 a.m.–2:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. FOR FURTHER INFORMATION CONTACT: Hylan Shoob, Ph.D., Scientific Review Officer, Center for Global Health, CDC, 1600 Clifton Road NE, Mailstop H21–9, Atlanta, Georgia 30329–4027, Telephone: (404) 639–4796; Email: HShoob@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone (404) 639–0913, MWalters@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–05749 Filed 3–17–22; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2022–05751 Filed 3–17–22; 8:45 am] Centers for Disease Control and Prevention BILLING CODE 4163–18–P jspears on DSK121TN23PROD with NOTICES1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel; (SEP)—GH20–002, Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Western Kenya; GH20–003, Conducting Public Health Research in Colombia; GH21–003, Advancing Public Health Research in Kenya; and GH22–001, Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Malaria and Other Parasitic Diseases. 18:27 Mar 17, 2022 Jkt 256001 Centers for Disease Control and Prevention [Docket No. CDC–2022–0037; NIOSH 278] Notice of Closed Meeting VerDate Sep<11>2014 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel; (SEP)—CE22–008, ‘‘Using Data Linkage To Improve Our Understanding of Suicide/Self-Inflicted Injury and/or Drowning’’; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE22– 008, ‘‘Using Data Linkage to Improve Our Understanding of Suicide/Selfinflicted Injury and/or Drowning’’, May 24–25, 2022, 8:30 a.m., EDT–5:30 p.m., EDT, Videoconference, in the original FRN. The meeting was published in the Federal Register on January 14, 2022, Volume 87, Number 10, page/s/2440– 2441. The meeting is being amended to change the meeting date and should read as follows: CE22–008, ‘‘Using Data Linkage to Improve Our Understanding of Suicide/ Self-inflicted Injury and/or Drowning’’, May 24, 2022, 1:00 p.m., EDT–5:00 p.m., EDT. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Mikel Walters, Ph.D., Scientific Review PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting and request for comment. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following virtual meeting of the Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH). This is a virtual meeting and open to the public, limited only by web conference lines (500 web conference lines are available). Time will be available for public comment. DATES: The meeting will be held on April 20, 2022, from 10:00 a.m.–3:00 p.m., EDT. Written comments must be submitted by April 13, 2022. ADDRESSES: This is a virtual meeting. You may submit comments, identified by Docket No. CDC–2022–0037; NIOSH–278 by mail. CDC does not accept comments by email. • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: Docket number CDC–2021– 0037; NIOSH–278, c/o Sherri Diana, NIOSH Docket Office, National Institute SUMMARY: E:\FR\FM\18MRN1.SGM 18MRN1

Agencies

[Federal Register Volume 87, Number 53 (Friday, March 18, 2022)]
[Notices]
[Page 15432]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05751]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel; (SEP)--GH20-002, Malaria Operations 
Research to Improve Malaria Control and Reduce Morbidity and Mortality 
in Western Kenya; GH20-003, Conducting Public Health Research in 
Colombia; GH21-003, Advancing Public Health Research in Kenya; and 
GH22-001, Enhancing Capacity for Strategic and Applied Research 
Activities in Support of Control and Elimination of Malaria and Other 
Parasitic Diseases.
    Date: April 13, 2022.
    Time: 9:00 a.m.-2:00 p.m., EDT.
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.

FOR FURTHER INFORMATION CONTACT:  Hylan Shoob, Ph.D., Scientific Review 
Officer, Center for Global Health, CDC, 1600 Clifton Road NE, Mailstop 
H21-9, Atlanta, Georgia 30329-4027, Telephone: (404) 639-4796; Email: 
[email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-05751 Filed 3-17-22; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.